Clincosm LogoSign in Get a demo

Breast Cancer

Showing NaN - NaN of 405
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

l Device in Assistance of Detection and Diagnosis of Breast

Completed
  • Breast Cancer
  • Mammography
  • Boston, Massachusetts
    Atrius Health
Nov 9, 2022

Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Boston

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +2 more
Nov 3, 2022

Breast Cancer, Myocardial Fibrosis, Radiation-Induced Fibrosis Trial in Boston (Losartan, Radiation Therapy)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Nov 1, 2022

Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY159 Single agent dose level 1, PY159 Single

Recruiting
  • Advanced Solid Tumor
  • +7 more
  • PY159 Single agent dose level 1
  • +17 more
  • San Francisco, California
  • +11 more
Nov 3, 2022

Genetic Testing, Breast Cancer, Ovarian Cancer Trial in Boston (Video Education, Genetic Counseling)

Recruiting
  • Genetic Testing
  • +8 more
  • Video Education
  • Genetic Counseling
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Oct 31, 2022

Breast Cancer, Invasive Breast Cancer, Unresectable Breast Carcinoma Trial in Boston (Onvansertib, Paclitaxel)

Recruiting
  • Breast Cancer
  • +9 more
  • Boston, Massachusetts
  • +2 more
Oct 25, 2022

Breast Cancer Trial in Boston (Abemaciclib)

Terminated
Has Results
  • Breast Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Oct 3, 2022

Breast Cancer Trial in Boston, Pittsburgh, Dallas (Nivolumab, Ipilimumab)

Active, not recruiting
Has Results
  • Breast Cancer
  • Boston, Massachusetts
  • +2 more
Oct 21, 2022

Breast Cancer Trial in Worldwide (DS-8201a)

Active, not recruiting
Has Results
  • Breast Cancer
  • Anchorage, Alaska
  • +98 more
Oct 17, 2022

Glioma, Glioma, Malignant, Glioma, Mixed Trial in United States (NUV-422)

Terminated
  • Glioma
  • +23 more
  • Tucson, Arizona
  • +11 more
Sep 30, 2022

Coronary Artery Disease, Atrial Fibrillation, Type 2 Diabetes Trial in Boston (Polygenic risk score (PRS))

Recruiting
  • Coronary Artery Disease
  • +5 more
  • Polygenic risk score (PRS)
  • Boston, Massachusetts
    VA Boston Healthcare System
Sep 29, 2022

Breast Cancer, Colorectal Cancer, Ovarian Cancer Trial in United States (ATRC-101, Pembrolizumab, Pegylated liposomal

Recruiting
  • Breast Cancer
  • +15 more
  • ATRC-101
  • +2 more
  • Phoenix, Arizona
  • +10 more
Sep 28, 2022

Breast Cancer Trial in United States (Letrozole, Ribociclib, Placebo)

Active, not recruiting
  • Breast Cancer
  • Little Rock, Arkansas
  • +12 more
Sep 24, 2022

Breast Cancer, Invasive Breast Cancer, in Situ Breast Cancer Trial in Boston (Standard Genetic Counseling, Quantitative Genetic

Recruiting
  • Breast Cancer
  • +3 more
  • Standard Genetic Counseling
  • Quantitative Genetic Counseling
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Sep 26, 2022

Breast Cancer Trial in Boston (Diffuse Optical Spectroscopy Imaging (DOSI) - Neoadjuvant Chemo (NAC) Cohort, Diffuse Optical

Enrolling by invitation
  • Breast Cancer
  • Diffuse Optical Spectroscopy Imaging (DOSI) - Neoadjuvant Chemo (NAC) Cohort
  • Diffuse Optical Spectroscopy Imaging (DOSI) - Non-NAC Cohort
  • Boston, Massachusetts
    Boston Medical Center
Sep 20, 2022

Advanced Solid Tumor, Breast Cancer, Small-cell Lung Cancer Trial in United States (SY-5609, Fulvestrant, Gemcitabine)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Gilbert, Arizona
  • +16 more
Sep 13, 2022

Breast Cancer, Stage III Breast Cancer, Breast Cancer Female Trial in Boston (THRIVE, Health Education Support Program)

Not yet recruiting
  • Breast Cancer
  • +4 more
  • THRIVE
  • Health Education Support Program
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Sep 8, 2022

Biomarkers in Subjects With Untreated Solid Tumors

Completed
  • Breast Cancer
  • +12 more
  • Blood Sample Collection
  • Phoenix, Arizona
  • +118 more
Aug 31, 2022

Malignant Tumor of Breast, Breast Cancer Trial in United States (Genomically Directed Monotherapy, Observation/Standard Therapy)

Active, not recruiting
  • Malignant Neoplasm of Breast
  • Breast Cancer
  • Genomically Directed Monotherapy
  • Observation/Standard Therapy
  • Birmingham, Alabama
  • +28 more
Aug 30, 2022

Breast Cancer Trial in United States (T-DM1)

Active, not recruiting
  • Breast Cancer
  • Duarte, California
  • +13 more
Aug 25, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Breast Cancer Trial in Boston (Communication Tool)

Completed
Has Results
  • Breast Cancer
  • Communication Tool
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 1, 2022

Breast Cancer Trial in Boston (Pembrolizumab, Nab-Paclitaxel, Biopsy)

Active, not recruiting
  • Breast Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 22, 2022

Breast Cancer Trial in Worldwide (Amcenestrant, Palbociclib, Alpelisib)

Active, not recruiting
  • Breast Cancer
  • Denver, Colorado
  • +30 more
Aug 18, 2022

Breast Cancer Trial in Worldwide (LY3484356)

Recruiting
  • Breast Cancer
  • Atlanta, Georgia
  • +19 more
Aug 17, 2022